Table 3 Practitioner-associated delay factors
Author(s) | Location | Study type | Participants | Cancer site | Factors that increase delay | Factors that decrease delay | No impact on delay | Strength of evidence |
---|---|---|---|---|---|---|---|---|
Texas, USA | Retrospective observational | 73 patients (aged <40; 48% men, 52% women) | Stomach | Initial misdiagnosis | Â | Â | Moderate | |
Japan | Retrospective observational | 536 patients | Stomach | Initial misdiagnosis | Â | Â | Insufficient | |
England | Prospective observational | 150 patients (21% with stomach cancer), 105 GPs | Stomach |  | Cancer site – stomach | Regular consulting rate of patient | Moderate | |
Finland | Retrospective observational | 162 patients (aged 38–82, mean 63; 59% men, 41% women) | Oesophagus | Initial misdiagnosis |  |  | Insufficient | |
England | Prospective observational | 83 patients (mean 71; 64% men, 36% women) | Stomach | Acid suppression treatment; patient age – younger | Patient age – older; patient social class – lower |  | Moderate | |
Sweden | Prospective observational | 50 patients (aged 31–85, mean 68; 74% men, 26% women) | Stomach | Patient sex – female; comorbidity; previously negative results | Patient sex – male |  | Strong | |
England | Cohort | 2585 patients with dyspepsia (aged 40+) | Stomach | Initial misdiagnosis | Â | Â | Insufficient | |
Norway | Prospective observational | 1165 patients | Stomach | Patient sex – female | Referral to university hospital |  | Moderate | |
Indiana, USA | Prospective observational | 77 patients (aged 30–89, mean 59; 64% men, 36% women | Small intestine | Inappropriate tests |  |  | Moderate | |
England | Retrospective observational | 245 GPs, 1465 patients (>60 with upper GI cancer) | Oesophagus, stomach | Cancer site – oesophagus |  |  | Moderate | |
Greece | Observational | 100 patients (aged 40–90; 64% men, 36% women) | Stomach | Initial misdiagnosis |  |  | Insufficient | |
California, USA | Retrospective observational | 49 patients (median 57; 45% men, 55% women) | Stomach | Inaccurate tests | Â | Â | Strong | |
England | Prospective observational | 115 patients (aged 31–89, median 66; 61% men, 39% women) | Oesophagus, stomach | Frequent attendance by patient; cancer site – oesophagus | Access to rapid screening (open access endoscopy) | Initial symptom | Insufficient | |
Ireland | Prospective observational | 100 patients (aged 37–83, median 69; 70% men, 30% women) | Oesophagus | Acid suppression treatment; initial misdiagnosis; inappropriate tests |  |  | Moderate | |
England | Retrospective observational | 133 patients (aged 38–97, mean 69; 53% men, 47% women) | Oesophagus, stomach | Acid suppression treatment |  |  | Strong | |
Spain | Prospective observational | 217 patients (aged 59–74, mean 65; 59% men, 41% women), 27% with upper GI cancer | Oesophagus, stomach |  | Comorbidity; symptom type – pain, bleeding |  | Strong | |
England | Observational | 90 patients (72% with oesophageal, 28% with gastric) | Oesophagus, stomach | Â | Use of referral guidelines; 2-week rule | Â | Strong | |
Italy | Cross-sectional | 706 endoscopy referrals (aged 15–86, mean 47; 55% men, 45% women) | Stomach | Inappropriate use of endoscopya |  |  | Strong | |
Singapore | Retrospective observational | 44 patients (aged 36–83, mean 67; 70% men, 30% women) | Stomach | Previously negative results |  |  | Moderate |